Vaneck Biotech Etf Fundamentals
| BBH Etf | USD 167.03 1.59 0.96% |
VanEck Biotech ETF fundamentals help investors to digest information that contributes to VanEck Biotech's financial success or failures. It also enables traders to predict the movement of VanEck Etf. The fundamental analysis module provides a way to measure VanEck Biotech's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to VanEck Biotech etf.
VanEck |
VanEck Biotech ETF ETF Beta Analysis
VanEck Biotech's Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Current VanEck Biotech Beta | 0.86 |
Most of VanEck Biotech's fundamental indicators, such as Beta, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, VanEck Biotech ETF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
| Competition |
In accordance with the recently published financial statements, VanEck Biotech ETF has a Beta of 0.86. This is much higher than that of the VanEck family and significantly higher than that of the Health category. The beta for all United States etfs is notably lower than that of the firm.
VanEck Biotech ETF Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VanEck Biotech's current stock value. Our valuation model uses many indicators to compare VanEck Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VanEck Biotech competition to find correlations between indicators driving VanEck Biotech's intrinsic value. More Info.VanEck Biotech ETF is second largest ETF in price to earning as compared to similar ETFs. It is third largest ETF in price to book as compared to similar ETFs fabricating about 0.16 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for VanEck Biotech ETF is roughly 6.45 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the VanEck Biotech's earnings, one of the primary drivers of an investment's value.VanEck Beta Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses VanEck Biotech's direct or indirect competition against its Beta to detect undervalued stocks with similar characteristics or determine the etfs which would be a good addition to a portfolio. Peer analysis of VanEck Biotech could also be used in its relative valuation, which is a method of valuing VanEck Biotech by comparing valuation metrics of similar companies.VanEck Biotech is currently under evaluation in beta as compared to similar ETFs.
Fund Asset Allocation for VanEck Biotech
The fund invests 99.96% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.Asset allocation divides VanEck Biotech's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
VanEck Biotech returns are very sensitive to returns on the market. As the market goes up or down, VanEck Biotech is expected to follow.
VanEck Fundamentals
| Price To Earning | 17.66 X | |||
| Price To Book | 2.74 X | |||
| Price To Sales | 4.72 X | |||
| Beta | 0.86 | |||
| Total Asset | 478.42 M | |||
| One Year Return | 9.70 % | |||
| Three Year Return | (5.20) % | |||
| Five Year Return | 3.80 % | |||
| Ten Year Return | 3.90 % | |||
| Net Asset | 478.42 M | |||
| Last Dividend Paid | 0.47 | |||
| Equity Positions Weight | 99.96 % |
About VanEck Biotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze VanEck Biotech ETF's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of VanEck Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of VanEck Biotech ETF based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States.
Currently Active Assets on Macroaxis
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:Check out VanEck Biotech Piotroski F Score and VanEck Biotech Altman Z Score analysis. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.